Vitamin B6: What the Label Doesn't Warn You About

Vitamin B6 can be hiding in a bottle you bought for something else. A magnesium product for cramps, a zinc blend for winter, a multivitamin, an “energy” formula: each may contain pyridoxine. One tablet can look modest. Two or three products taken every day can turn a routine into a much larger exposure than the shopper intended.

That matters because peripheral neuropathy, a disorder affecting nerves outside the brain and spinal cord, is a known adverse effect of supplemental vitamin B6. Medsafe published a New Zealand safety update in June 2025 after receiving reports linked to pyridoxine-containing products. The practical lesson is not that food containing B6 is dangerous, or that every supplement causes harm. It is simpler: B6 deserves the same label check people already give caffeine, iron, vitamin D and herbal ingredients.

Vitamin B6 is essential, but the required amount is small

Vitamin B6 is a family name for related compounds. Pyridoxine is the form most commonly printed on supplement labels. In the body, B6 participates in amino-acid metabolism, haemoglobin formation and the production of certain neurotransmitters. The NIH Office of Dietary Supplements notes that it is involved in more than 100 enzyme reactions. These are ordinary, necessary functions, which is why B6 appears so frequently in products marketed for energy or general wellbeing.

Essential does not mean that large supplemental doses are automatically useful. The New Zealand and Australian Nutrient Reference Values place the recommended intake for adults aged 19 to 50 at 1.3 mg per day. The figure is 1.7 mg for men aged 51 and over and 1.5 mg for women aged 51 and over. Pregnancy and breastfeeding have their own recommendations. Medsafe summarises the relevant daily range across ages and sexes as 0.5 to 1.7 mg a day.

Those numbers give a useful sense of scale. A label offering 25 mg, 50 mg or 100 mg is not just a little above a general nutrition target. It is a different kind of decision, particularly when it is part of a stack of products rather than a clinician-directed plan.

It also helps to understand why B6 requirements shift with age and life stage rather than staying fixed at one number. Infants rely on breast milk or formula for an adequate intake, so no upper level has been set for that group; the safe approach for infants is food, not supplements. Requirements rise through childhood and adolescence as growth accelerates, and they rise again for people over 51, reflecting research showing older adults need more B6 to maintain the same blood marker of adequate status. Pregnancy adds roughly another 0.5 mg a day above the non-pregnant requirement, and breastfeeding adds more again, because some B6 is secreted into breast milk. None of these life-stage increases comes close to the tens of milligrams found on many supplement labels; they are measured in tenths of a milligram.

Food sources do not look like a supplement stack

B6 occurs naturally in a wide range of foods. The NIH lists fish, beef liver and other organ meats, potatoes and other starchy vegetables, and non-citrus fruit among richer sources. Chickpeas, chicken, tuna, salmon, fortified cereals and bananas can all contribute. A mixed diet provides B6 in amounts that sit very differently from concentrated tablets.

A cup of canned chickpeas in the NIH food table supplies about 1.1 mg. A medium banana or a cup of boiled potato provides about 0.4 mg. A three-ounce serving of roasted chicken breast provides about 0.5 mg. Those examples are not a meal plan, and nutrient values vary with product and preparation. They do show why “food first” is a sensible starting point for someone whose aim is simply to meet normal nutrition needs.

Food can also put a label claim in perspective. A tablet carrying 50 mg of pyridoxine is not comparable with the B6 in a banana, even if both are described with the same nutrient name. The label should state the amount per recommended daily dose, not merely the amount per capsule. Start there.

Bioavailability adds another layer that a food label alone will not show. Roughly 75 percent of the vitamin B6 in a typical mixed diet is absorbed and usable, according to the NIH fact sheet. Some plant foods contain a form called pyridoxine glucoside, which is only about half as bioavailable as B6 from other food sources or supplements, meaning a strict plant-based eater relying heavily on that form may need a slightly higher intake to reach the same functional status as someone eating a varied diet. This is a reason to favour dietary variety over assumptions, and, where genuinely needed, to discuss a modest, food-level supplement with a health professional rather than defaulting to a high-strength product bought for an unrelated reason.

The problem is often the total, not one dramatic bottle

The most important B6 number may be the sum of every supplement you take. This is easy to miss because B6 is commonly added to products whose main marketing message has nothing to do with B vitamins. Medsafe specifically notes that multivitamin and mineral preparations, including products intended for zinc and magnesium, may contain B6.

The Australian Therapeutic Goods Administration reached the same concern while reviewing adverse-event reports. In its 2022 safety update, it said some people did not realise that products they used for magnesium contained vitamin B6. Nine of the 32 reports it assessed involved multiple products containing B6. A person can therefore be exposed through a multivitamin in the morning, a “stress” blend at lunch and a magnesium product in the evening without ever seeking out a dedicated B6 tablet.

Try a cupboard audit rather than trusting memory:

• Gather every vitamin, mineral, sleep, energy, sports and “stress support” product.
• Find vitamin B6, pyridoxine, pyridoxal 5-phosphate or P5P in the active-ingredient panel.
• Record the amount provided by the labelled daily serving, not the amount per single capsule when the serving is two capsules.
• Add the daily totals for products used on the same day.
• Include medicines and products recommended by another practitioner in the list you show a pharmacist or doctor.

This is not a diagnosis tool and it cannot tell you whether a particular dose is appropriate for you. It can stop a basic arithmetic error before it becomes a long-term habit.

Supplement labels do not always use the same wording for the ingredient you are counting. Pyridoxine hydrochloride is common. Some products list pyridoxal 5-phosphate or P5P, an active coenzyme form. A buyer may assume the names refer to unrelated ingredients, especially in a busy blend with magnesium, zinc, botanical extracts and several B vitamins.

For a safety audit, do not treat a different form name as a free pass. Look for any declared vitamin B6 amount, note the unit, and include it in the total you discuss with a pharmacist or clinician. The TGA lists pyridoxine hydrochloride, pyridoxal 5-phosphate and pyridoxal 5-phosphate monohydrate as forms available in products. Its point is practical: label terminology can vary while the need to recognise B6 remains.

Be precise about units as well. B6 is usually shown in milligrams. Vitamin B12 is often displayed in micrograms, and the numbers can look much larger or smaller simply because the units differ. Do not compare the numerals without reading “mg” or “mcg”. And do not assume that a high percentage daily intake is an instruction to seek a higher dose. It is a statement about the product, not personal medical advice.

Tingling and numbness are signals to take seriously

Peripheral neuropathy has many possible causes. Diabetes, infections, metabolic conditions, toxins and other medical problems can be involved. That is why pins and needles, burning, numbness, pain, weakness or reduced sensation should not be self-diagnosed from a supplement label alone.

Still, B6 exposure belongs in the conversation. Medsafe describes possible neuropathy symptoms as burning, tingling, pricking sensations, heightened sensitivity, weakness, reduced reflexes and pain. The TGA describes the condition as tingling, burning or numbness, usually in the hands or feet. These are symptoms for prompt clinical assessment, particularly if they are new, persistent or worsening.

“Long-term use of high doses of vitamin B6 is associated with severe peripheral neuropathy. However, cases have also been reported in patients taking lower doses for a prolonged period.” — Medsafe, Vitamin B6 (pyridoxine) and peripheral neuropathy, 5 June 2025

The quote is deliberately cautious. It does not prove B6 is the cause of any individual’s symptoms. It explains why a prescriber needs the complete list of supplements as well as prescribed medicines, alcohol intake, health conditions and the pattern of symptoms. Do not wait for a perfect theory before seeking advice if symptoms affect walking, balance, hands or feet.

What New Zealand regulators have reported

Medsafe’s June 2025 update reported six New Zealand cases from 1 January 2010 to 28 February 2025 in which the suspect medicine was a pyridoxine-containing product and symptoms were suggestive of peripheral neuropathy. Five of those reports named a dietary supplement containing B6 as the suspect product. A report is not proof of causation in the way a controlled trial is. It is, however, a safety signal that warrants attention from regulators, clinicians and consumers.

New Zealand dietary supplements operate under the Dietary Supplements Regulations 1985, which set rules including labelling and maximum daily doses for certain listed vitamins and minerals. Medsafe explains that dietary supplements are not assessed through a pre-market approval process before they are supplied; responsibility for complying with the rules remains with the supplier. That makes clear product information and careful shopping especially important.

There is a separate pathway for supplemented foods. The New Zealand Food (Supplemented Food) Standard 2016 sets a maximum per one-day quantity of 25 mg for pyridoxine in supplemented food. When the total amount exceeds 10 mg per day, the standard requires an advisory statement that the food is intended only for people aged 14 or over. These figures apply to that food standard, not as a personal prescription or a universal safety threshold.

The current Nutrient Reference Values for Australia and New Zealand list an upper level of intake of 50 mg per day for adults, expressed as pyridoxine. An upper level is not a target. It is an intake level above which the risk of adverse effects increases for the general population. The reference values are also under review, so readers should check current official guidance rather than treating any older chart as permanent.

Australia changed its warning rules after safety reports

New Zealanders often see Australian brands and Australian product information, so the TGA’s actions are useful context rather than a substitute for New Zealand rules. After reviewing reports, the TGA required a peripheral-neuropathy warning on listed medicines with daily vitamin B6 doses above 10 mg. It also reduced the maximum permitted daily dose in those adult products from 200 mg to 100 mg.

The TGA said its review found that neuropathy could occur below 50 mg, and that it had not identified a minimum dose, duration of use or specific patient risk factor that would rule risk in or out. Of the 32 reports with sufficient information for a possible causal association, 21 involved daily B6 doses of 50 mg or less. This does not mean that everyone taking a low-dose product will develop neuropathy. It means “under 50 mg” should not be read as a guarantee of no risk, especially when products are combined.

Australia’s exact warning requirement is not a New Zealand label rule. The transferable habit is more valuable: recognise B6 wherever it appears, add up the labelled daily amounts, and seek individual advice rather than treating a number printed on a bottle as a promise of safety or benefit.

The TGA’s review sits within a broader pattern the agency has continued to update. Reporting in late 2025 noted that some blood-testing pathologists in Australia were seeing a meaningful share of samples returning results consistent with likely nerve involvement, and that regulators were weighing further sale restrictions for higher-strength products, including a possible move to pharmacist-only supply. That regulatory conversation is ongoing and specific to Australia, so New Zealand shoppers should not assume identical rules apply here. What is consistent across both countries is the underlying clinical signal: peripheral neuropathy linked to B6 is being reported often enough, and at low enough doses in some cases, that health authorities on both sides of the Tasman have chosen to act rather than wait.

Claims about energy, mood and PMS need separate evidence

Vitamin B6 has a legitimate metabolic role, but that is not evidence for every claim printed beside it. “Energy” on a product can refer to ordinary nutrient metabolism rather than a demonstrated treatment for fatigue. Persistent fatigue can arise from sleep disruption, iron deficiency, thyroid disease, depression, infection, medication effects and many other causes. A high-dose B6 product should not become a substitute for investigating a symptom that continues.

PMS is another area where the label can run ahead of the evidence. A 2007 trial by Kashanian and colleagues reported an improvement in PMS severity with pyridoxine compared with placebo. Earlier reviews and clinical discussions have varied in their conclusions, and the safety questions around chronic high-dose use remain relevant. A small or single study is not enough to convert B6 into a universal self-treatment for mood changes, bloating or cycle symptoms.

Pregnancy nausea is a distinct clinical situation. Pyridoxine can be part of clinically directed care for nausea and vomiting in pregnancy, sometimes in combination with other medicines. The Cochrane evidence summary says B6 may help reduce nausea in pregnancy, while noting that routine supplementation has been assessed separately. Pregnancy is not the moment to copy a dose from social media, borrow a B-complex or combine several products. Ask the midwife, GP, pharmacist or obstetric team what is suitable for your own symptoms and current medicines.

Vitamin B6 toxicity from food alone is considered extremely rare, and the mechanism behind supplement-related nerve injury is still not fully understood. Researchers believe excess B6 may interfere with how the neurotransmitter GABA signals to sensory nerves, but why some people develop neuropathy at moderate doses while others tolerate higher amounts without symptoms remains an open question. That uncertainty is itself a reason for caution rather than confidence: without a reliably identified low-risk threshold or a way to predict who is vulnerable, a conservative approach to unnecessary high-dose B6 makes more sense than experimenting to see what a particular body can tolerate.

A safer way to use the label

A good label-reading habit takes less time than shopping for another “wellness” blend. Turn the bottle around before you buy it. Look for the active ingredients, serving size and daily directions. A product marketed around magnesium or zinc still needs a B6 check. A multivitamin should be included in the same audit. Two products that each look low on their own may not be low together.

Use this short decision guide:

• You eat a varied diet and have no clinical reason for extra B6: compare your usual food intake with the modest reference values before assuming a high-strength supplement is needed.
• You are considering B6 for a symptom: ask what is causing the symptom and whether the claim has evidence for that situation.
• You already take several products: calculate the daily total and take the bottles or photographs of their labels to a pharmacist.
• You are pregnant, breastfeeding, taking prescription medicines, or managing a chronic condition: get individual advice before adding or changing a supplement.
• You notice tingling, burning, numbness, weakness or balance changes: seek medical advice promptly and mention every product containing B6. Do not assume the symptom is harmless or that B6 is definitely the cause.

The point is informed caution, not panic. A label can tell you what a product provides. It cannot tell you whether you need it, whether it overlaps with the rest of your cupboard, or whether it explains a new symptom. Those questions require context.

Supplements are not reviewed like prescription medicines

Many people see a neat label, a health-food-store shelf or a familiar vitamin name and infer that a product has been individually evaluated for the specific claim it makes. That is not how New Zealand dietary supplements are regulated. Medsafe says dietary supplements must meet the applicable regulations, including requirements on composition, labelling and maximum daily doses where these apply, but they do not go through a government approval process before being placed on the market.

This distinction matters most when a product uses language that sounds medical. A dietary supplement must not be presented with a stated or implied therapeutic purpose under the regulations. Claims to prevent, diagnose, treat or cure illness cross a different regulatory line. If a B6 product appears to promise a cure for neuropathy, depression, hormonal problems or unexplained exhaustion, take that as a reason to step back, not as evidence that it is a better option.

A pharmacist can help compare ingredients across products and check known medicine interactions or duplication. A GP or relevant clinician can investigate symptoms and decide whether testing or treatment is needed. That is a much better route than escalating the dose because a bottle’s front label sounds persuasive.

It is also worth knowing which groups deserve a lower threshold for seeking advice rather than trying to work it out alone. People with reduced kidney function, including those on dialysis, process water-soluble vitamins differently and may be more vulnerable to accumulation. People with autoimmune conditions such as rheumatoid arthritis, coeliac disease, Crohn’s disease or ulcerative colitis, and people with a history of alcohol dependence, are flagged by the NIH consumer fact sheet as groups who may be more likely to have altered B6 status. None of this means such a person cannot safely use a B6-containing product. It means the ordinary "check the label yourself and decide" approach is a weaker fit for these situations, and a pharmacist or prescriber should be involved before, not after, a new supplement is added to an existing regimen.

What this means for your next purchase

Vitamin B6 is a normal part of food and normal physiology. The current safety issue is concentrated exposure, especially exposure that is accidental because B6 sits inside products bought for another reason. The most useful action is not to memorise a single “safe” number. It is to know your total, understand that personal circumstances matter, and treat neurological symptoms as a reason for medical advice rather than another supplement experiment.

Before you buy a magnesium, zinc, multivitamin or energy product, find the B6 line. Before you add a second product, add the milligrams. And if tingling, numbness, burning or weakness has entered the picture, bring the bottles to a pharmacist or doctor. A clearer label read today can prevent a confusing supplement stack tomorrow.

None of this is an argument against vitamin B6 as a nutrient. It occurs naturally in ordinary meals, it does real metabolic work, and most people who eat a varied diet already meet their needs without thinking about milligrams at all. The caution here is specifically about concentrated, cumulative and sometimes accidental supplement exposure, which is a solvable problem with a five-minute label check rather than a reason to avoid food sources of B6 or to distrust every product on the shelf.

Sources: Medsafe; Therapeutic Goods Administration; New Zealand legislation and MPI supplemented-food standard; NHMRC and New Zealand Ministry of Health Nutrient Reference Values; NIH Office of Dietary Supplements; Cochrane.

Sources

www.medsafe.govt.nz

www.tga.gov.au

www.mpi.govt.nz

www.legislation.govt.nz

www.nhmrc.gov.au

ods.od.nih.gov

ods.od.nih.gov

theconversation.com

eveningreport.nz

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

This article is for general education and does not replace advice from a qualified healthcare professional.